Novo Nordisk Pharmatech will contribute to the scientific agenda at BPI Digital Week
Novo Nordisk Pharmatech will contribute to the scientific agenda at BioProcess International Digital Week (Dec 7-10) with a presentation on upgrading cell stem cultures.
Theis Guldbech will join Dr. Geraldine Dhiew, Senior Scientist in Esco Aster PTE LTD’s Stem Cell Department, to describe stem cell culture optimization using a combination of Novo Nordisk Pharmatech’s GMP grade TrypsiNNex™ trypsin enzyme, now in final development, and Esco Aster BioNOC™ II macrocarriers.
The webinar will outline the advantages of using TrypsiNNex in 2D and 3D with BioNOC II macrocarriers in cell cultures when compared to available state-of-the-art benchmark proteins, covering cell dissociation, reseeding, cell differentiation and phenotypic markers.
We will also present findings from studies of 3D BioNOC II carriers and tide motion bioreactors for large scale manufacturing of cells.
This work has identified optimal concentrations for 2D and 3D culture detachment and compares this new combination with adipogenic, chondrogenic and osteogenic differentiation for confirming of cell line identity post detachment from 3D carriers by surface marker characterization.
The live webinar series are free to attend. You can sign up here: BioProcessing International Fall Digital Week (informaengage.com)